Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes

Brunson, Ann; Ho, Gwendolyn; White, Richard; Wun, Theodore

doi:10.1016/s0049-3848(16)30112-8

Cited by 26 publications

(15 citation statements)

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Since the 1990s, the use of IVC filters has increased markedly, despite limited evidence of their efficacy. To date, the only universal recommendation for IVC filters is for acute treatment of proximal DVT or PE in patients with absolute contraindications to anticoagulation . Randomized trials assessing outcomes of IVC filter placement that only included patients who also were treated with anticoagulants did not find a clear benefit .…”

Section: Discussionmentioning

confidence: 99%

Isolated Clot, Real Error

2019

AORN Journal

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Isolated Clot, Real Error

2019

AORN Journal

View full text Add to dashboard Cite

“…In an observational study of 2747 cancer patients who had an IVC filter placed between 2005 and 2009, no reduction in short-term mortality or PE prevention was demonstrated. 59 Other than the possible exception of a patient with recent acute VTE AND a contraindication for anticoagulant therapy, we do not think the evidence of benefit from IVC filters justifies their risk.…”

Section: Patients With Thrombocytopeniamentioning

confidence: 92%

Managing thrombosis in cancer patients

Wang

García

2018

Research and Practice in Thrombosis and Haemostasis

View full text Add to dashboard Cite

Venous thromboembolism is a major complication in cancer patients. The basis for the strong association between cancer and thrombosis remains incompletely understood, and the optimal approaches to both the treatment and the prevention of cancer‐associated thrombosis are evolving. Here we review several important topics related to cancer‐associated thromboembolism, including the pathogenesis, prevention, and management of this disease. Wherever possible, we include evidence from clinical trials, including the results of recently published trials that compared direct oral anticoagulants to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis.

show abstract

“…The study showed no benefit for short-term mortality (30-day) and no reduction in recurrent PE. However, it reported a 60% increased risk of DVT [42]. This high rate of DVT in the setting of IVC insertion is reflective of the persistently heightened prothrombotic state in cancer patients, which is not suppressed by IVC filters.…”

Section: Ivc Filter For Acute Cancer-associated Thrombosismentioning

confidence: 97%

Inferior vena cava filters

Duffett

Carrier

2017

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

To cite this article: Duffett L, Carrier M. Inferior vena cava filters. J Thromb Haemost 2017; 15: 3-12.Summary. Use of inferior vena cava (IVC) filters has increased dramatically in recent decades, despite a lack of evidence that their use has impacted venous thromboembolism (VTE)-related mortality. This increased use appears to be primarily driven by the insertion of retrievable filters for prophylactic indications. A growing body of evidence, however, suggests that IVC filters are frequently associated with clinically important adverse events, prompting a closer look at their role. We sought to narratively review the current evidence on the efficacy and safety of IVC filter placements. Inferior vena cava filters remain the only treatment option for patients with an acute (within 2-4 weeks) proximal deep vein thrombosis (DVT) or pulmonary embolism and an absolute contraindication to anticoagulation. In such patients, anticoagulation should be resumed and IVC filters removed as soon as the contraindication has passed. For all other indications, there is insufficient evidence to support the use of IVC filters and high-quality trials are required. In patients where an IVC filter remains, regular follow-up to reassess removal and screen for filter-related complications should occur.

show abstract

Inferior vena cava filters in patients with cancer and venous thromboembolism (VTE): patterns of use and outcomes

Cited by 26 publications

References 54 publications

Isolated Clot, Real Error

Isolated Clot, Real Error

Managing thrombosis in cancer patients

Inferior vena cava filters

Contact Info

Product

Resources

About